TSL [Trina Solar] 20-F:

[] [Wholly-Owned Subsidiaries 1. Top Energy International Limited, a Hong Kong company 2. Changzhou Trina Solar Energy Co., Ltd., a PRC company 3. Trina Solar Korea Limited, a South Korean company 4. Trina Solar (Singapore) Pte. Ltd., a Singapore company 5. Trina Solar (Hong Kong) Enterprise Limited, a Hong Kong company 6. Trina Solar (Luxembourg) Holdings S.à.r.l, a Luxembourg company 7.] [CERTIFICATIONS I, Jifan Gao, certify that: 1. I have reviewed this annual report on Form 20-F of Trina Solar Limited. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Terry Wang, certify that: 1. I have reviewed this annual report on Form 20-F of Trina Solar Limited (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jifan Gao Chairman and Chief Executive Officer] [CERTIFICATIONS (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Terry Wang Chief Financial Officer] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-160826 on Form F-3 and Nos. 333-144445 and 333-157831 on Form S-8 of our reports dated April 18, 2011, relating to the financial statements and financial statement schedule of Trina Solar Limited, and the effectiveness of Trina Solar Limited’s internal control over]

By | 2016-03-17T13:59:08+00:00 April 18th, 2011|Categories: Chinese Stocks, TSL, Webplus ver|Tags: , , , , , |0 Comments

CCCL [China Ceramics] 6-K: (Original Filing)

[Copy of correspondence to: Stuart Management Company 33 Riverside Avenue th 5 Westport, CT 06880 x ¨ Form 20-F ¨ ¨ ¨ x Yes 1 Other Events. Company China Ceramics Co., Ltd. (the “ · On April 13, 2011, Paul Kelly purchased 20,000 of the Company’s shares for an aggregate purchase price of $89,020. · On April 13, 2011, William]

By | 2016-03-21T19:27:43+00:00 April 18th, 2011|Categories: CCCL, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

CCCL [China Ceramics] 6-K: Copy of correspondence to: Stuart Management Company 33

[Copy of correspondence to: Stuart Management Company 33 Riverside Avenue th 5 Westport, CT 06880 x ¨ Form 20-F ¨ ¨ ¨ x Yes 1 Other Events. Company China Ceramics Co., Ltd. (the “ · On April 13, 2011, Paul Kelly purchased 20,000 of the Company’s shares for an aggregate purchase price of $89,020. · On April 13, 2011, William]

By | 2016-03-21T19:28:34+00:00 April 18th, 2011|Categories: CCCL, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Biotech Files Clinical Trial Applications with SFDA for its Proprietary Pneumococcal Polysaccharides Vaccines (PPV) -Completes Pre-Clinical Studies- Source: Sinovac Biotech Ltd. On Monday January 31, 2011, 8:00 am EST BEIJING, Jan. 31, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today the submission of the applications to commence human] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.]

By | 2016-03-24T02:03:42+00:00 April 18th, 2011|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Biotech Files Clinical Trial Applications with SFDA

[Sinovac Biotech Files Clinical Trial Applications with SFDA for its Proprietary Pneumococcal Polysaccharides Vaccines (PPV) -Completes Pre-Clinical Studies- Source: Sinovac Biotech Ltd. On Monday January 31, 2011, 8:00 am EST BEIJING, Jan. 31, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today the submission of the applications to commence human] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.]

By | 2016-03-24T02:05:19+00:00 April 18th, 2011|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV) -Completes Pre-Clinical Studies- Source: Sinovac Biotech Ltd. On Thursday March 3, 2011, 8:00 am EST BEIJING, March 3, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.]

By | 2016-03-24T02:06:51+00:00 April 18th, 2011|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Biotech Submits Clinical Trial Application to SFDA

[Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV) -Completes Pre-Clinical Studies- Source: Sinovac Biotech Ltd. On Thursday March 3, 2011, 8:00 am EST BEIJING, March 3, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.]

By | 2016-03-24T02:08:04+00:00 April 18th, 2011|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

AMC [AMC ENTERTAINMENTS,] S-1/A: (Original Filing)

[AMENDMENT FORM S-1 REGISTRATION STATEMENT AMC ENTERTAINMENTS,INC. Delaware 7832 26-0303916 c/o AMC EntertainmentInc. Kevin M.nnor, Esq. (Name,dress,luding zipde, and telephone number,luding areade, ofent for service)pies ofmmunications to: Monica K. Thurmond, Esq. Matthew D. Bloch, Esq. Weil, Gotshal& MangesLLP Approximatete ofmmencement of proposedle to public:] [QuickLinks -- Click here to rapidly navigate through this document [OMM LETTERHEAD] April18, 2011 AMC Entertainments,Inc. Re: Registration of Securities of AMC Entertainments,Inc. Ladies and Gentlemen Registration Statementmmon Stock "), to be sold by the stockholders of thempany (the " Securities "). Respectfully submitted, EX-5.1 a2203385zex-5_1.htm 2] [QuickLinks -- Click here to rapidly navigate through this document AMC ENTERTAINMENTS,INC. AND SUBSIDIARIES (AND JURISDICTION OF ORGANIZATION) AMC EntertainmentInc. (Delaware) AMC EuropeS.A. (France) Movietickets.com,Inc. (Delaware) (26.2%) LCE AcquisitionSub,Inc. (Delaware) LCE Mexicans,Inc. (Delaware) LCE Lux HoldCo S. r.l. (Luxembourg) American Multi-Cinema,Inc. (Missouri) Club Cinema of Mazza.Inc. (District oflumbia)] [QuickLinks -- Click here to rapidly navigate through this documentNSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to the use in this Amendment No.4 to the Registration Statement on FormS-1 of our reportted May26, 2009, except for earnings (loss) per share discussed in Note1 to thensolidated Financial Statements, to which thete is July9, 2010,] [QuickLinks -- Click here to rapidly navigate through this documentNSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The Board of Directors Wensent to the use of our reportted June29, 2010, with respect to thensolidated balance sheet of AMCEntertainments, (and subsidiaries) of April1, 2010, and the relatednsolidated statements of operations, stockholders' equity, andsh flows for the year] [QuickLinks -- Click here to rapidly navigate through this documentNSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Wensent to the use in this Amendment No.4 to Registration Statement No.333-168105 of AMCEntertainments, on Form S-1 of our reportted February24, 2011 related to the financial statements of National CineMedia, appearing in the prospectus, which is part of this] [QuickLinks -- Click here to rapidly navigate through this documentNSENT OF INDEPENDENT AUDITORS Wensent to the use in this Amendment No.4 to Registration Statement No.333-168105 on FormS-1 of our reportted July13, 2010 related to the financial statements of the Kerasotes Showplace Theatres Sold to AMCEntertainment (the "Theatres") of December31, 2009 and 2008 and for the]

By | 2016-02-04T03:56:49+00:00 April 18th, 2011|Categories: AMC, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

RENN [Renren] F-1/A: (Original Filing)

[PROSPECTUS (SUBJECT TO COMPLETION) ISSUED APRIL 18, 2011 53,100,000 American Depositary Shares Renren Inc. Representing 159,300,000 Class A Ordinary Shares This is an initial public offering of American depositary shares, or ADSs, of Renren Inc. Each ADS represents three Class A ordinary shares of Renren Inc., par value US$0.001 per share. We are offering 42,898,711 ADSs, and the selling shareholders] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Registration Statement on Form F-1 of our report dated April 15, 2011 relating to the consolidated financial statements of Renren Inc. and its subsidiaries and variable interest entities as of December 31, 2009 and 2010, and for the each of the three years in the period]

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group Unblinded Results Show Good Safety Profile and Preliminary Immunogenicity Source: Sinovac Biotech Ltd. On Thursday March 10, 2011, 8:00 am EST BEIJING, March 10, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today the unblinding] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.]

By | 2016-03-24T02:09:11+00:00 April 18th, 2011|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments
Skip to toolbar